Tower Research Capital LLC (Trc) Bausch Health Companies Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,664 shares of BHC stock, worth $18,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,664
Previous 15,583
82.9%
Holding current value
$18,354
Previous $127,000
83.46%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$239 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$190 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$182 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$106 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$89.6 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.49B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...